The 52-week high and low prices can offer valuable insights into a stock’s current standing and prospects for future performance. Bionano Genomics Inc.’s current trading price is -90.03% away from its 52-week high, while its distance from the 52-week low is 1.69%. The stock’s price range for this period has been between $2.95 and $30.10 The company’s shares, which are part of the Healthcare sector, had a trading volume of approximately 0.74 million for the day, a number notably lower than the average daily volume of 1.11 million over the last three months.
The present stock price for Bionano Genomics Inc. (BNGO) is $3.00. In the last trading session, the stock made a considerable jump, reaching $3.24 after an opening price of $3.24. The stock briefly fell to $2.99 before ending the session at $3.25.
In today's chaotic marketplace, the biggest gains will come from some currently-small companies that pass by older, larger businesses still stuck in a pre-pandemic world. The trick is figuring out which small caps will be tomorrow's winners. That's why StockWire News has put together a special Wealth Building Report, highlighting 3 small cap stocks set to soar in 2023.
Click here for full details and to join for free
Bionano Genomics Inc. experienced a somewhat shaky performance in the stock market. The company’s stock reached a 1-year high of $30.10 on 11/15/22, while the lowest price for the same period was registered at $2.95 on 08/21/23.
Exploring Financial Performance and Market Capitalization: A Comprehensive Analysis
Bionano Genomics Inc. (BNGO) has experienced a quarterly decline of -57.74% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 110.58M and boasts a workforce of 405 employees.
Analyzing Trading Volume and Moving Average Trends
Based on Barchart.com data, the company’s moving average over the 100-day period was 5.66, with a change in price of -4.35. Similarly, Bionano Genomics Inc. recorded 1,018,464 in trading volume during the last 100 days, posting a change of -59.21%.
Understanding Ticker ‘s Debt-to-Equity Ratio: An Analysis
The debt-to-equity (D/E) ratio serves as an important indicator of a company’s financial stability and market position. By dividing a company’s total liabilities by its shareholders’ equity, the D/E ratio reveals the degree to which a company relies on debt to finance assets compared to its shareholders’ equity. At the time of writing, the total D/E ratio for BNGO stands at 0.02. Similarly, the long-term debt-to-equity ratio is also 0.02.
BNGO Stock Stochastic Average
Bionano Genomics Inc.’s raw stochastic average for the past 50 days is presently 1.31%, as of today. This marks a decrease from the raw stochastic average of the last 20 days, which was 4.00%. Additionally, the company’s Stochastic %K and %D values for the past 20 days were 21.07% and 30.49%, respectively.
BNGO Stock Price Performance Analysis
The stock price performance over the year has been a mixed bag, resulting in a range of outlooks from optimistic to pessimistic depending on the observer. The index has shown a price loss of -79.45% this year. Over the last six months, there has been a stronger performance of -73.45%. The price of BNGO leaped by -1.32% during the last 30 days period. For the last 5-days stocks have slided -14.04%.
